| Not Yet Recruiting | Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements NCT06630338 | Mayo Clinic | — |
| Not Yet Recruiting | Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients NCT07286396 | Tanta University | — |
| Withdrawn | Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography NCT05516485 | University of Southern California | N/A |
| Enrolling By Invitation | Cryoablation of Brain Neoplasm NCT06753617 | Erasmus Medical Center | N/A |
| Suspended | Surgical Resection of Latent Brain Tumors Prior to Recurrence NCT04810871 | Mayo Clinic | N/A |
| Active Not Recruiting | Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma NCT04553757 | M.D. Anderson Cancer Center | — |
| Completed | Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions NCT04132843 | M.D. Anderson Cancer Center | N/A |
| Active Not Recruiting | MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation NCT05087888 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With NCT03606161 | M.D. Anderson Cancer Center | N/A |
| Unknown | Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escala NCT02672995 | National Taiwan University Hospital | Phase 1 |
| Withdrawn | Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors NCT03234309 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects NCT02798406 | DNAtrix, Inc. | Phase 2 |
| Terminated | Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery NCT02855086 | Eben Rosenthal | Phase 1 / Phase 2 |
| Recruiting | Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors NCT02754544 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastom NCT02861898 | Northwell Health | Phase 1 / Phase 2 |
| Recruiting | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Re NCT02800486 | Northwell Health | Phase 2 |
| Completed | Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial S NCT02964416 | Aga Khan University | Phase 4 |
| Recruiting | Tumor Related Epilepsy NCT02639325 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Unknown | 18F-FET PET in Childhood Brain Tumours NCT03216148 | Charite University, Berlin, Germany | Phase 2 |
| Active Not Recruiting | Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy NCT01503086 | Children's Oncology Group | N/A |
| Unknown | Subclavian Vein catheterization_Seldinger Vs Modified Seldinger NCT02090010 | Seoul National University Hospital | N/A |
| Completed | Assessing the Patient Experience in Cancer Care NCT01621295 | Mayo Clinic | — |
| Withdrawn | Bevacizumab With or Without Surgery for Adult Glioblastomas NCT01413438 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
| Completed | BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tum NCT01124461 | Washington University School of Medicine | — |
| Terminated | An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Pr NCT00880061 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 |
| Terminated | Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 A NCT00638963 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors NCT00747253 | Monteris Medical | Phase 1 |
| Completed | Hypertonic Saline 75% vs Mannitol 20% NCT00199511 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases NCT00124761 | Royal Adelaide Hospital | Phase 3 |
| Completed | Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. NCT00040573 | TransMolecular | Phase 1 / Phase 2 |
| Completed | Brain Neoplasms, Leukemia and Petrochemical Exposures NCT00042445 | National Institute of Environmental Health Sciences (NIEHS) | — |
| Completed | Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant G NCT02755142 | medac GmbH | Phase 1 / Phase 2 |
| Completed | Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury NCT00178295 | University of Rochester | — |
| Completed | A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Me NCT00001574 | National Cancer Institute (NCI) | — |
| Completed | PET Scan of Brain Metabolism in Relation to Age and Disease NCT00001972 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Gene Therapy for the Treatment of Brain Tumors NCT00001328 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 |
| Completed | Evaluation of Factors in Human Brain Tumors NCT00001171 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas NCT00080054 | Pharmacyclics LLC. | Phase 1 |